TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 75 filers reported holding TARSUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 4.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $130,148 | -25.7% | 7,324 | -24.4% | 0.00% | – |
| Q2 2023 | $175,080 | +247.3% | 9,689 | +141.6% | 0.00% | – |
| Q1 2023 | $50,406 | +16.8% | 4,010 | +36.3% | 0.00% | – |
| Q4 2022 | $43,144 | -18.6% | 2,943 | -5.2% | 0.00% | – |
| Q3 2022 | $53,000 | +17.8% | 3,106 | +2.0% | 0.00% | – |
| Q2 2022 | $45,000 | -43.0% | 3,045 | -35.4% | 0.00% | – |
| Q1 2022 | $79,000 | -54.1% | 4,713 | -38.4% | 0.00% | – |
| Q4 2021 | $172,000 | -18.1% | 7,654 | -21.8% | 0.00% | – |
| Q3 2021 | $210,000 | +233.3% | 9,784 | +404.1% | 0.00% | – |
| Q1 2021 | $63,000 | -52.3% | 1,941 | -39.2% | 0.00% | – |
| Q4 2020 | $132,000 | – | 3,193 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,084,370 | $30,432,000 | 4.62% |
| Vivo Capital, LLC | 2,312,368 | $33,761,000 | 3.39% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $26,098,000 | 2.46% |
| Cormorant Asset Management, LP | 1,875,000 | $27,375,000 | 2.07% |
| Sands Capital Ventures, LLC | 260,000 | $3,796,000 | 1.04% |
| Ghost Tree Capital, LLC | 120,000 | $1,752,000 | 0.91% |
| RTW INVESTMENTS, LP | 2,013,601 | $29,399,000 | 0.76% |
| COWEN AND COMPANY, LLC | 534,524 | $7,804,000 | 0.75% |
| Perceptive Advisors | 1,296,416 | $18,927,000 | 0.59% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,324,214 | $19,334,000 | 0.40% |